AHIP Study Compares Claims Data with CDC Opioid Prescribing Guidelines
America’s Health Insurance Plans today released findings from a study assessing health insurance claims from 2009 to 2013 on six recommendations from the Centers for Disease Control and Prevention’s Guideline for Prescribing Opioids for Chronic Pain. According to AHIP, the vast majority of opioid prescriptions for chronic pain were for immediate-release opioids, consistent with CDC recommendations, but certain other measures could be improved. For example, about one-quarter of opioid prescriptions were above the CDC-recommended morphine milligram equivalent dosage, the organization said. The study methodology has been shared with insurance providers nationwide, who may apply it to measure their own opioid prevention and management efforts.
Related News Articles
Headline
A KFF survey published today found that people view prior authorization as the biggest challenge beyond costs when navigating the health care system. In terms…
Headline
The Centers for Medicare & Medicaid Services Jan. 29 issued a final rule regarding states non-uniform or non-broad-based provider tax, as authorized under…
Headline
The Department of Health and Human Services Office of Inspector General Jan. 27 released a bulletin addressing how direct-to-consumer drug programs can sell…
Headline
The Centers for Medicare & Medicaid Services Jan. 27 announced 15 drugs under Medicare Parts D and B selected for the third round of price negotiations.…
Headline
A KFF analysis released Jan. 28 found that Medicare Advantage insurers made nearly 53 million prior authorization determinations in 2024, an increase…
Headline
The AHA Jan. 26 released a white paper on addressing challenges in implementing an advanced explanation of benefits, which requires coordination among multiple…